DESCRIPTION:
Private Sector Partnerships-One (PSP-One) is a worldwide project funded by USAID as part of a wider USAID effort to meet health goals through private sector channels and decrease dependence on donors and government. PSP-One has a primary objective of providing leadership, innovation and technical direction to private sector in the fields of reproductive health and voluntary family planning (RH/FP) behaviors, products and services and related health behaviors.

PSP-One India provides technical assistance (TA) in developing strategies for expanding the marketing of health products and services to urban and rural areas through innovative channels, effective mass media, local communication and market research to better understand the needs of providers and consumers and monitor campaigns.  PSP-One endeavors to strengthen partnerships with commercial manufacturers and professional associations by advocating collaboration and policy change.  PSP-One also provides training for chemists, para-medics, doctors and other health care providers.

KEY ACTIVITIES:

•  Increase the basket of contraceptives by provision of three-monthly injectables through the private sector in 45 cities in Uttar Pradesh (UP), Uttarakhand (UK) and Jharkhand (JH).

•  Promote quality assurance and the correct use of DMPA (Depot Medroxyprogesterone Acetate ).through training doctors and paramedics and counseling potential users.

•  Generate demand through local and mass media, advocate for an increased basket of contraceptives, and develop private sector product supply channels.

KEY ACHIEVEMENTS OF ABOVE INITIATIVES:

•  PSP-One created a favorable environment for DMPA use in the project areas. The program successfully scaled up from three city pilots in UP to 45 cities across UP, UK and JH.

•  More than 1,700 health providers trained in FP including provision of DMPA; more than 1,150 providers enrolled in DIMPA Network.

•  Increased industry investment on DIMPA- four companies distributing DMPA across northern India, including the project areas; DMPA available at different price points: $1 to $3 (compared to only one manufacturer at the start of the project selling at $4 per vial)

Demonstrated that it is possible to provide quality injectable contraceptive services through the private sector.

<< Back